84 related articles for article (PubMed ID: 23494264)
1. Regulation of p38, PKC/Foxo3a/p73 signaling network by GTP during erythroid differentiation in chronic myelogenous leukemia.
Meshkini A; Yazdanparast R
Cell Biochem Biophys; 2013 Nov; 67(2):675-87. PubMed ID: 23494264
[TBL] [Abstract][Full Text] [Related]
2. Foxo3a targets mitochondria during guanosine 5'-triphosphate guided erythroid differentiation.
Meshkini A; Yazdanparast R
Int J Biochem Cell Biol; 2012 Nov; 44(11):1718-28. PubMed ID: 22743331
[TBL] [Abstract][Full Text] [Related]
3. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
5. FoxO3a and nilotinib-induced erythroid differentiation of CML-BC cells.
Wang W; Li NN; Du Y; Lv FF; Lin GQ
Leuk Res; 2013 Oct; 37(10):1309-14. PubMed ID: 23915976
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.
Ho KK; McGuire VA; Koo CY; Muir KW; de Olano N; Maifoshie E; Kelly DJ; McGovern UB; Monteiro LJ; Gomes AR; Nebreda AR; Campbell DG; Arthur JS; Lam EW
J Biol Chem; 2012 Jan; 287(2):1545-55. PubMed ID: 22128155
[TBL] [Abstract][Full Text] [Related]
7. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C
PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
Sanchez-Prieto R; Sanchez-Arevalo VJ; Servitja JM; Gutkind JS
Oncogene; 2002 Jan; 21(6):974-9. PubMed ID: 11840343
[TBL] [Abstract][Full Text] [Related]
10. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
[TBL] [Abstract][Full Text] [Related]
11. CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells.
Huang SY; Liu YH; Chen YJ; Yeh YY; Huang HM
J Cell Physiol; 2018 Sep; 233(9):7467-7479. PubMed ID: 29663362
[TBL] [Abstract][Full Text] [Related]
12. Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.
Yang Y; Liu X; Xiao F; Xue S; Xu Q; Yin Y; Sun H; Xu J; Wang H; Zhang Q; Wang H; Wang L
PLoS One; 2015; 10(2):e0117573. PubMed ID: 25688862
[TBL] [Abstract][Full Text] [Related]
13. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells.
Wang L; Jiang R; Song SD; Hua ZS; Wang JW; Wang YP
Asian Pac J Cancer Prev; 2015; 16(9):3715-21. PubMed ID: 25987027
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P
Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649
[TBL] [Abstract][Full Text] [Related]
15. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
16. FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1.
Birkenkamp KU; Essafi A; van der Vos KE; da Costa M; Hui RC; Holstege F; Koenderman L; Lam EW; Coffer PJ
J Biol Chem; 2007 Jan; 282(4):2211-20. PubMed ID: 17132628
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2013 Dec; 87(12):2119-27. PubMed ID: 23673518
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C downregulation induces senescence via FoxO3a inhibition in HCT116 and HEK293 cells.
Park JW; Lee YH; Bae YS
Biochem Biophys Res Commun; 2017 Dec; 493(4):1548-1554. PubMed ID: 28989024
[TBL] [Abstract][Full Text] [Related]
20. The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression.
Hui RC; Gomes AR; Constantinidou D; Costa JR; Karadedou CT; Fernandez de Mattos S; Wymann MP; Brosens JJ; Schulze A; Lam EW
Mol Cell Biol; 2008 Oct; 28(19):5886-98. PubMed ID: 18644865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
